Family summary
Historical shortage references are available across related Octreotide acetate presentations from multiple manufacturers.
- 0 current shortage context pages.
- 11 historical shortage context pages.
- 4 manufacturers represented.
Octreotide acetate - Drug Shortage Information
Public shortage context is available across 11 visible exact NDC pages for this generic family.
This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.
Common brands and presentations in this family
These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.
octreotide acetate 50 ug / mL Injection 1 mL - NDC 67457-0239-01Mylan Institutional LLC | 10 Syringeoctreotide acetate 100 ug / mL Injection 1 mL - NDC 67457-0245-01Mylan Institutional LLC | 10 Syringeoctreotide acetate Kit 1 Kit (Sandostatin LAR Depot) - NDC 00078-0818-81Novartis Pharmaceuticals Corporation | 1 Kitoctreotide acetate Kit 1 Kit (Sandostatin LAR Depot) - NDC 00078-0825-81Novartis Pharmaceuticals Corporation | 1 KitOctreotide Acetate 100 ug / mL Injection 1 mL - NDC 63323-0376-01Fresenius Kabi USA, LLC | 10 Vial, Single-Dose
Exact NDC product pages in this shortage family
Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.